HIV Infection

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...

The FDA has approved a new option for HIV-1 pre-exposure prophylaxis to reduce HIV-1 infection risk from sex, excluding in those who have receptive vaginal sex.

The FDA has approved a new option for treatment-experienced adults with HIV infection.

The US Food and Drug Administration has approved the smallest integrase strand transfer inhibitor-based triple-therapy single tablet regimen for adults with HIV-1.

After 2 clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved the first complete HIV treatment regimen containing only 2 drugs.

After successful results from a pivotal clinical trial, a new dosage for an integrase inhibitor was approved by the FDA.

The FDA has approved a new, daily, fixed-dose combination therapy for HIV treatment, and a new add-on treatment for severe, poorly-controlled asthma.